Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT04793958
Other study ID # 849-010
Secondary ID KRYSTAL-10
Status Active, not recruiting
Phase Phase 3
First received
Last updated
Start date March 15, 2021
Est. completion date February 28, 2026

Study information

Verified date March 2024
Source Mirati Therapeutics Inc.
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Study 849-010 is an open-label, randomized Phase 3 clinical trial comparing the efficacy of MRTX849 administered in combination with cetuximab versus chemotherapy in the second-line treatment setting in patients with CRC with KRAS G12C mutation.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 461
Est. completion date February 28, 2026
Est. primary completion date February 28, 2025
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Histologically confirmed diagnosis of colorectal carcinoma with KRAS G12C mutation in tumor tissue. - Prior receipt of 1st line treatment in advanced CRC with a fluoropyrimidine-based chemotherapy regimen containing either oxaliplatin or irinotecan, and radiographically documented progression of disease on or after treatment. Exclusion Criteria: - Prior treatment with a therapy targeting KRAS G12C mutation (e.g., AMG 510). - Prior treatment with an anti-EGFR antibody (e.g., cetuximab or panitumumab). - Active brain metastasis

Study Design


Intervention

Drug:
MRTX849
28 Day Cycle
Biological:
Cetuximab
28 Day Cycle
Drug:
mFOLFOX6 Regimen
Fluorouracil Oxaliplatin Folinic acid
FOLFIRI Regimen
Fluorouracil Irinotecan Folinic acid

Locations

Country Name City State
Argentina Research Site Buenos Aires
Argentina Research Site Buenos Aires
Argentina Research Site Buenos Aires
Argentina Research Site La Rioja
Argentina Research Site Viedma Rio Negro
Australia Research Site Bedford Park South Australia
Australia Research Site Clayton Victoria
Australia Research Site Garran
Australia Research Site Heidelberg Victoria
Australia Research Site Melbourne Victoria
Australia Research Site Waratah New South Wales
Austria Research Site Innsbruck Tyrol
Austria Research Site Wien
Austria Research Site Wiener Neustadt
Belgium Research Site Brussels
Belgium Research Site Edegem Antwerpen
Belgium Research Site Gent
Belgium Research Site Yvoir
Brazil Research Site Blumenau Santa Catarina
Brazil Research Site Curitiba
Brazil Research Site Ijuí
Brazil Research Site Porto Alegre Rio Grande Do Sul
Brazil Research Site Porto Alegre Rio Grande Do Sul
Brazil Research Site Sao Paulo
Brazil Research Site São Paulo
Brazil Research Site São Paulo
Brazil Research Site São Paulo
Brazil Research Site São Paulo
Brazil Research Site São Paulo
Canada Research Site Montréal Quebec
Canada Research Site Ottawa Ontario
Canada Research Site Toronto Ontario
Canada Research Site Toronto
China Research Site Beijing
China Research Site Beijing
China Research Site Bengbu Anhui
China Research Site Changchun Jilin
China Research Site Changchun Jilin
China Research Site Changsha Hunan
China Research Site Changsha Hunan
China Research Site Chengdu Sichuan
China Research Site Fuzhou Fujian
China Research Site Guangzhou Guang Dong
China Research Site Hangzhou Zhejiang
China Research Site Hangzhou Zhejiang
China Research Site Harbin Heilongjiang
China Research Site Hefei Anhui
China Research Site Hefei Anhui
China Research Site Jinan Shandong
China Research Site Nanchang Jiangxi
China Research Site Nanjing Jiangsu
China Research Site Nanning Guangxi
China Research Site Neijiang Sichuan
China Research Site Shanghai Pudong
China Research Site Shanghai
China Research Site Shanghai
China Research Site Shanghai
China Research Site Shanghai
China Research Site Shenyang Liaoning
China Research Site Shenyang Liaoning
China Research Site Shenzhen Guang Dong
China Research Site Tianjin
China Research Site Wuhan Hubei
China Research Site Wuxi Jiangsu
China Research Site Xi'an
China Research Site Zhengzhou Henan
Colombia Research Site Barranquilla
Colombia Research Site Bogotá
Colombia Research Site Floridablanca Santander
Colombia Research Site Medellín
Czechia Research Site Brno South Moravian
Czechia Research Site Brno South Moravian
Czechia Research Site Olomouc
Czechia Research Site Prague
Czechia Research Site Praha Prague
Denmark Research Site Copenhagen
Denmark Research Site Odense
Denmark Research Site Vejle
Finland Research Site Helsinki
Finland Research Site Tampere
Finland Research Site Turku
France Research Site Avignon Provence Alpes Cote d'Azure
France Research Site Besançon Doubs
France Research Site Bourdeaux Rhone
France Research Site Brest Bretagne
France Research Site Dijon Bourgogne
France Research Site Lille Hauts-de-France
France Research Site Lyon Rhone-Alpes
France Research Site Marseille
France Research Site Paris
France Research Site Paris
France Research Site Paris
France Research Site Paris Ile-de-France
France Research Site Pessac
France Research Site Suresnes
France Research Site Toulouse Midi-Pyrenees
France Research Site Tours
France Research Site Villejuif Val-de-Marne
Germany Research Site Amberg
Germany Research Site Berlin
Germany Research Site Bochum Nordrhein-Westfalen
Germany Research Site Dresden Sachsen
Germany Research Site Frankfurt Hessen
Germany Research Site Hamburg
Germany Research Site Herne
Germany Research Site Monchengladbach
Germany Research Site München
Germany Research Site München Bayern
Germany Research Site Reutlingen Baden-Wurttemberg
Germany Research Site Ulm Baden-Wuerttemberg
Greece Research Site Athens
Greece Research Site Athens
Greece Research Site Heraklion
Greece Research Site Larissa Thessaly
Greece Research Site Thessaloniki
Greece Research Site Thessaloníki
Hong Kong Research Site Central
Hong Kong Research Site Hong Kong
Ireland Research Site Dublin
Ireland Research Site Dublin
Ireland Research Site Dublin
Ireland Research Site Dublin
Italy Research Site Avellino
Italy Research Site Biella
Italy Research Site Cagliari
Italy Research Site Candiolo Torino
Italy Research Site Lido Di Camaiore Lucca
Italy Research Site Meldola
Italy Research Site Milan
Italy Research Site Milano
Italy Research Site Naples
Italy Research Site Padova
Italy Research Site Pisa
Italy Research Site Reggio Emilia
Italy Research Site Roma
Italy Research Site Turin
Korea, Republic of Research Site Anyang-si Gyeonggi-do
Korea, Republic of Research Site Busan
Korea, Republic of Research Site Busan
Korea, Republic of Research Site Daejeon
Korea, Republic of Research Site Goyang-si
Korea, Republic of Research Site Hwasun Jeollanam-do
Korea, Republic of Research Site Seongnam-si Gyeonggi-do
Korea, Republic of Research Site Seoul
Korea, Republic of Research Site Seoul
Korea, Republic of Research Site Seoul
Korea, Republic of Research Site Seoul
Korea, Republic of Research Site Seoul
Korea, Republic of Research Site Seoul
Korea, Republic of Research Site Sowon
Korea, Republic of Research Site Yangsan Gyeongsangnam
Malaysia Research Site Johor Bahru
Malaysia Research Site Kota Kinabalu Sabah
Malaysia Research Site Kuala Lumpur Selangor
Malaysia Research Site Kuala Lumpur Selangor
Malaysia Research Site Petaling Jaya Selangor
Malaysia Research Site Putrajaya
Mexico Research Site Cuernavaca Morelos
Mexico Research Site Guadalajara Jalisco
Mexico Research Site Guadalajara Jalisco
Mexico Research Site Mexico City
Mexico Research Site San Juan Del Río Queretaro
Mexico Research Site Tuxtla Gutiérrez Chiapas
Mexico Research Site Veracruz
Netherlands Research Site Amsterdam Noor-Holland
Netherlands Research Site Amsterdam Noord-Holland
Netherlands Research Site Nieuwegein Utrecht
Netherlands Research Site Nijmegen Gelderland
Poland Research Site Gdansk
Poland Research Site Otwock
Poland Research Site Warsaw
Poland Research Site Warsaw
Portugal Research Site Braga
Portugal Research Site Lisboa
Portugal Research Site Lisbon
Portugal Research Site Porto
Portugal Research Site Porto
Puerto Rico Research Site San Juan
Puerto Rico Research Site San Juan
Romania Research Site Baia Mare
Romania Research Site Brasov
Romania Research Site Bucuresti
Romania Research Site Cluj-Napoca
Romania Research Site Cluj-Napoca
Romania Research Site Craiova
Romania Research Site Ovidiu Constanta
Romania Research Site Timisoara
Singapore Research Site Singapore
Singapore Research Site Singapore
Singapore Research Site Singapore
Singapore Research Site Singapore
Singapore Research Site Singapore
Spain Research Site A Coruña
Spain Research Site Badalona Barcelona
Spain Research Site Barcelona
Spain Research Site Barcelona
Spain Research Site Barcelona
Spain Research Site Córdoba
Spain Research Site Madrid
Spain Research Site Madrid
Spain Research Site Madrid
Spain Research Site Madrid
Spain Research Site Pamplona
Spain Research Site Sabadell
Spain Research Site Santander
Spain Research Site Valencia
Spain Research Site Valencia
Taiwan Research Site Changhua
Taiwan Research Site Kaohsiung
Taiwan Research Site Taichung
Taiwan Research Site Tainan
Taiwan Research Site Tainan
Taiwan Research Site Taipei
Taiwan Research Site Taoyuan
Thailand Research Site Bangkok
Thailand Research Site Bangkok
Thailand Research Site Bangkok
Thailand Research Site Chiang Mai
Thailand Research Site Hat Yai
United Kingdom Research Site Aberdeen Scotland
United Kingdom Research Site Birmingham England
United Kingdom Research Site Bournemouth Dorset
United Kingdom Research Site Cambridge England
United Kingdom Research Site Glasgow Scotland
United Kingdom Research Site Leeds England
United Kingdom Research Site London England
United Kingdom Research Site London England
United Kingdom Research Site Maidstone England
United Kingdom Research Site Manchester England
United Kingdom Research Site Middlesex England
United Kingdom Research Site Sutton England
United States Research Site Bakersfield California
United States Research Site Baltimore Maryland
United States Research Site Baton Rouge Louisiana
United States Research Site Belleville New Jersey
United States Research Site Birmingham Alabama
United States Research Site Boston Massachusetts
United States Research Site Chattanooga Tennessee
United States Research Site Cincinnati Ohio
United States Research Site Clovis California
United States Research Site Dallas Texas
United States Research Site Dallas Texas
United States Research Site Denver Colorado
United States Research Site Detroit Michigan
United States Research Site Everett Washington
United States Research Site Fairfax Virginia
United States Research Site Florham Park New Jersey
United States Research Site Fort Myers Florida
United States Research Site Fredericksburg Virginia
United States Research Site Fullerton California
United States Research Site Gilbert Arizona
United States Research Site Goodyear Arizona
United States Research Site Houston Texas
United States Research Site Houston Texas
United States Research Site Indianapolis Indiana
United States Research Site Iowa City Iowa
United States Research Site Jacksonville Florida
United States Research Site Jacksonville North Carolina
United States Research Site Las Vegas Nevada
United States Research Site Lincoln Nebraska
United States Research Site Longview Texas
United States Research Site Los Angeles California
United States Research Site Los Angeles California
United States Research Site Milwaukee Wisconsin
United States Research Site Minneapolis Minnesota
United States Research Site Morgantown West Virginia
United States Research Site Naperville Illinois
United States Research Site Nashville Tennessee
United States Research Site New Brunswick New Jersey
United States Research Site New York New York
United States Research Site New York New York
United States Research Site New York New York
United States Research Site Norwich Connecticut
United States Research Site Ocala Florida
United States Research Site Oklahoma City Oklahoma
United States Research Site Oklahoma City Oklahoma
United States Research Site Omaha Nebraska
United States Research Site Orlando Florida
United States Research Site Orlando Florida
United States Research Site Phoenix Arizona
United States Research Site Port Jefferson Station New York
United States Research Site Redlands California
United States Research Site Richmond Virginia
United States Research Site Richmond Virginia
United States Research Site Rochester Minnesota
United States Research Site Saint Paul Minnesota
United States Research Site Saint Petersburg Florida
United States Research Site Saint Petersburg Florida
United States Research Site Salt Lake City Utah
United States Research Site San Antonio Texas
United States Research Site San Diego California
United States Research Site San Francisco California
United States Research Site Santa Monica California
United States Research Site Seattle Washington
United States Research Site Somerset New Jersey
United States Research Site Sparta North Carolina
United States Research Site Springdale Arkansas
United States Research Site Springfield Missouri
United States Research Site Sylmar California
United States Research Site Tacoma Washington
United States Research Site Tallahassee Florida
United States Research Site Temple Texas
United States Research Site Torrance California
United States Research Site Tulsa Oklahoma
United States Research Site Vancouver Washington
United States Research Site West Palm Beach Florida
United States Research Site Weston Florida
United States Research Site Whittier California
United States Research Site Zion Illinois

Sponsors (1)

Lead Sponsor Collaborator
Mirati Therapeutics Inc.

Countries where clinical trial is conducted

United States,  Argentina,  Australia,  Austria,  Belgium,  Brazil,  Canada,  China,  Colombia,  Czechia,  Denmark,  Finland,  France,  Germany,  Greece,  Hong Kong,  Ireland,  Italy,  Korea, Republic of,  Malaysia,  Mexico,  Netherlands,  Poland,  Portugal,  Puerto Rico,  Romania,  Singapore,  Spain,  Taiwan,  Thailand,  United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary Overall Survival (OS) Defined as time from date of randomization to date of death due to any cause. 30 months
Primary Progression-free Survival (PFS) Defined as time from randomization until disease progression or death from any cause, whichever occurs first. 30 months
Secondary Adverse Events Defined as number of patients with treatment emergent AEs. 30 months
Secondary Objective Response Rate (ORR) Defined as the percent of patients documented to have a confirmed CR or PR. 30 months
Secondary Duration of Response (DOR) Defined as the time from date of the first documentation of objective tumor response (CR or PR) to the first documentation of either Progression of Disease (PD) or death due to any cause, whichever occurs first. 30 months
Secondary Patient Reported Outcomes (PROs) To be assessed by European Quality of Life Questionnaire for Cancer Patients (QLQ-C30). 30 months
Secondary Quality of Life Assessment To be assessed by European Quality of Life Five Dimensions Questionnaire (EQ-5D-5L). 30 months
See also
  Status Clinical Trial Phase
Completed NCT01228734 - A Trial to Compare Oxaliplatin, Folinic Acid (FA) and 5-Fluorouracil (5FU) Combination Chemotherapy (FOLFOX-4) With or Without Cetuximab in the 1st Line Treatment of Metastatic Colorectal Cancer (mCRC) in Chinese Rat Sarcoma Viral Oncogene Homolog (RAS) Wild-type Patients Phase 3
Completed NCT05178745 - A Prospective Observational Cohort Study Evaluating Resection Rate in Patients With Metastatic Colorectal Cancer Treated With Aflibercept in Combination With FOLFIRI - Observatoire résection
Completed NCT01591421 - P13Kinase Inhibitor BKM120 in Combination With Panitumumab in Metastatic/Advanced RAS-Wild Type Colorectal Cancer. Phase 1/Phase 2
Withdrawn NCT05412706 - Niraparib Maintenance Treatment in mCRC With a Partial o Complete Response After Oxaliplatin-based Induction Therapy Phase 2
Withdrawn NCT04430985 - FOLFOX + Immunotherapy With Intrahepatic Oxaliplatin for Patients With Metastatic Colorectal Cancer Phase 2
Withdrawn NCT03182894 - Epacadostat in Combination With Pembrolizumab and Azacitidine in Subjects With Metastatic Colorectal Cancer Phase 1/Phase 2
Recruiting NCT05725200 - Study to Investigate Outcome of Individualized Treatment in Patients With Metastatic Colorectal Cancer Phase 2
Terminated NCT03176264 - PDR001 in Combination With Bevacizumab and mFOLFOX6 as First Line Therapy in Patients With Metastatic MSS Colorectal Cancer Phase 1
Completed NCT04866290 - HepaSphereâ„¢ Microspheres Prospective Registry
Not yet recruiting NCT05531045 - 18FFDG PET/CT for Early Evaluation of Chemotherapy Efficacy in Metastatic Colic Adenocarcinoma
Withdrawn NCT03982173 - Basket Trial for Combination Therapy With Durvalumab (Anti-PDL1) (MEDI4736) and Tremelimumab (Anti-CTLA4) in Patients With Metastatic Solid Tumors Phase 2
Completed NCT02906059 - Study of Irinotecan and AZD1775, a Selective Wee 1 Inhibitor, in RAS or BRAF Mutated, Second-line Metastatic Colorectal Cancer Phase 1
Active, not recruiting NCT02575378 - Maintenance Treatment With Capecitabine Metronomic Chemotherapy and Chinese Traditional Medicine in Metastatic Colorectal Cancer Phase 4
Withdrawn NCT02535988 - Abscopal Effect for Metastatic Colorectal Cancer Phase 2
Recruiting NCT02848807 - Chemotherapy-related Toxicity, Nutritional Status and Quality of Life N/A
Active, not recruiting NCT02077868 - Evaluation of MGN1703 Maintenance Treatment in Patients With mCRC With Tumor Reduction During Induction Treatment Phase 3
Completed NCT02414009 - Study to Compare CAPTEM vs FOLFIRI as Second Line Treatment in Advanced, Colorectal Cancer Patients Phase 2
Active, not recruiting NCT01949194 - Study to Determine the Efficacy of Regorafenib in Metastatic Colorectal Cancer Patients and to Discover Biomarkers Phase 2
Withdrawn NCT01915472 - A Phase II Study of IMMU 130 in Patients With Metastatic Colorectal Cancer Phase 2
Completed NCT01693848 - "Cancersensor" Metastasis Resection N/A